Włodzimierz Mazur Selected Research

IDX320

1/2012

Rapid decline of viral RNA in chronic hepatitis C patients treated once daily with IDX320: a novel macrocyclic HCV protease inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Włodzimierz Mazur Research Topics

Disease

19	Infections 05/2024 - 02/2002
15	Chronic Hepatitis C 07/2023 - 08/2003
9	Fibrosis (Cirrhosis) 05/2024 - 01/2010
6	COVID-19 12/2022 - 01/2021
4	Liver Diseases (Liver Disease) 07/2023 - 02/2002
4	Inflammation (Inflammations) 08/2022 - 01/2010
3	Coinfection 03/2024 - 02/2002
3	Hepatitis C 01/2022 - 01/2005
2	HIV Infections (HIV Infection) 05/2024 - 05/2021
2	Neoplasms (Cancer) 09/2022 - 05/2021
2	Liver Cirrhosis (Hepatic Cirrhosis) 07/2020 - 01/2018
2	Chronic Hepatitis B 01/2019 - 04/2002
2	Insulin Resistance 09/2012 - 01/2011
2	Chronic Hepatitis (Chronic Active Hepatitis) 12/2011 - 01/2011
2	Fatty Liver 01/2011 - 01/2010
2	Viremia 08/2003 - 08/2003
1	Hepatocellular Carcinoma (Hepatoma) 03/2024
1	Obesity 01/2024
1	Epilepsy (Aura) 07/2023
1	Mental Disorders (Mental Disorder) 07/2023
1	Embolism (Embolus) 09/2022
1	Pulmonary Embolism 09/2022
1	Disease Progression 08/2022
1	End Stage Liver Disease 05/2021
1	Hypertension (High Blood Pressure) 05/2021
1	Non-alcoholic Fatty Liver Disease 01/2010
1	Diabetes Mellitus 01/2010
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2010
1	Hepatitis B 04/2004
1	Chronic Kidney Failure (Chronic Renal Failure) 04/2004
1	Autoimmune Hepatitis 08/2003

Drug/Important Bio-Agent (IBA)

14	Antiviral Agents (Antivirals)IBA 05/2024 - 08/2003
8	InterferonsIBA 07/2023 - 01/2012
4	Ribavirin (Virazole)FDA LinkGeneric 01/2016 - 08/2003
4	RNA (Ribonucleic Acid)IBA 04/2004 - 02/2002
3	remdesivirIBA 12/2022 - 01/2021
3	AdipokinesIBA 12/2011 - 01/2010
3	DNA (Deoxyribonucleic Acid)IBA 04/2004 - 02/2002
2	Hepatitis B e AntigensIBA 01/2019 - 04/2002
2	Transaminases (Aminotransferases)IBA 10/2013 - 08/2003
2	Nicotinamide PhosphoribosyltransferaseIBA 01/2011 - 01/2010
2	Interferon alpha-2 (Roferon-A)FDA Link 01/2005 - 08/2003
1	fibrin fragment D (D-dimer)IBA 09/2022
1	Interleukin-6 (Interleukin 6)IBA 09/2022
1	InterleukinsIBA 08/2022
1	Benzo(a)pyreneIBA 08/2022
1	ProcalcitoninIBA 08/2022
1	Particulate MatterIBA 08/2022
1	COVID-19 VaccinesIBA 03/2022
1	VaccinesIBA 03/2022
1	sofosbuvir drug combination ledipasvirIBA 01/2022
1	C-Reactive ProteinIBA 05/2021
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2020
1	elbasvirIBA 07/2020
1	grazoprevirIBA 07/2020
1	paritaprevirIBA 03/2020
1	Ritonavir (Norvir)FDA Link 03/2020
1	dasabuvirIBA 03/2020
1	ombitasvirIBA 03/2020
1	entecavir FDA Link 01/2019
1	ledipasvirIBA 09/2017
1	telaprevirIBA 01/2016
1	ChemokinesIBA 01/2014
1	fibroblast growth factor 21IBA 09/2012
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2012
1	Viral RNAIBA 01/2012
1	IDX320IBA 01/2012
1	Glucose (Dextrose)FDA LinkGeneric 12/2011
1	Oxygen (Dioxygen)IBA 12/2011
1	LeptinIBA 01/2011
1	AdiponectinIBA 01/2011
1	nasIBA 01/2010
1	peginterferon alfa-2a (Pegasys)FDA Link 01/2005
1	Interferon-alpha2bIBA 11/2004
1	Erythropoietin FDA Link 04/2004
1	Biomarkers (Surrogate Marker)IBA 04/2004
1	Glutathione (Reduced Glutathione)IBA 08/2003
1	TransferasesIBA 08/2003
1	Lamivudine (Epivir)FDA Link 04/2002
1	Alanine Transaminase (SGPT)IBA 04/2002

Therapy/Procedure

20	Therapeutics 05/2024 - 04/2002
2	Duration of Therapy 03/2020 - 01/2012
1	Liver Transplantation 03/2024
1	Retreatment 01/2019
1	Bariatric Surgery 01/2010
1	Blood Transfusion (Blood Transfusions) 04/2004